DR. MAHER MAHMOUDDERMATOLOGY · LASER
Press coverageSkin conditions

FDA approval of first topical repigmentation drug for vitiligo

Published
By
إيمان البدري
Quoted in
Al-Ahram Gate
Editorial image for: FDA approval of first topical repigmentation drug for vitiligo

Summary

Discusses the FDA approval of Opzelura (ruxolitinib) cream for non-segmental vitiligo in patients aged 12 and older, explaining how JAK inhibitors restore pigment.

Discusses the FDA approval of Opzelura (ruxolitinib) cream for non-segmental vitiligo in patients aged 12 and older, explaining how JAK inhibitors restore pigment.

General information, not a diagnosis. For advice about your own skin, book a consultation. Book a consultation

PressSkin conditions

Common morning skincare mistakes that damage the skin over time

Explains that dry skin lacks natural oils, making it highly susceptible to inflammation and eczema, and stresses intensive daily moisturizing alongside avoiding hot water and harsh morning exfoliation.

Quoted in El-Consolto
PressSkin conditions

Himalayan salt for the skin: potential benefits and precautions

Highlights simple ways to protect dry skin from irritation and eczema by compensating for its lack of natural lipids through consistent hydration, while warning against overuse of salt baths.

Quoted in El-Consolto
PressSkin conditions

Skin fasting: how it affects the skin and precautions for dry skin

Examines the "skin fasting" trend and cautions individuals with dry skin that their skin barrier lacks natural lipids and requires regular moisturizing rather than complete product deprivation to avoid eczema and inflammation.

Quoted in El-Consolto

All articlesBook a consultation